About Helio Vision
Helio Vision is a company based in Waltham (United States) founded in 2016 was acquired by Aldeyra in January 2019. Helio Vision has raised $1.77 million across 3 funding rounds from investors including Aldeyra. Helio Vision operates in a competitive market with competitors including Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Helio Vision
Helio Vision has successfully raised a total of $1.77M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.02 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Helio Vision
Helio Vision has secured backing from 1 investor. Prominent investors backing the company include Aldeyra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
Locked | Locked | Locked |
Investor details for Helio Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Helio Vision
Investment portfolio details for Helio Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Helio Vision
Detailed financials for Helio Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Helio Vision Comparisons
Peer comparison for Helio Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Helio Vision
Helio Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| Locked | Locked | Locked |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
|
Detailed competitors of Helio Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Helio Vision
Complete news archive for Helio Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Helio Vision
Helio Vision was founded in 2016.
Helio Vision is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Helio Vision is a funded company, having raised a total of $1.77M across 3 funding rounds to date.
Helio Vision was established in 2016 and is based in Waltham, United States. Small molecule-based therapeutics targeting eye diseases, with a primary focus on proliferative vitreoretinopathy, are being advanced by the company within the biotechnology sector. The lead product candidate, ADX-2191, has been progressed through Phase 2 clinical trials for treatment applications. Operations center on therapeutic development for ocular conditions.
Helio Vision's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Helio Vision has 1 investor. Key investors include Aldeyra.